JP2002540168A5 - - Google Patents

Download PDF

Info

Publication number
JP2002540168A5
JP2002540168A5 JP2000607657A JP2000607657A JP2002540168A5 JP 2002540168 A5 JP2002540168 A5 JP 2002540168A5 JP 2000607657 A JP2000607657 A JP 2000607657A JP 2000607657 A JP2000607657 A JP 2000607657A JP 2002540168 A5 JP2002540168 A5 JP 2002540168A5
Authority
JP
Japan
Prior art keywords
dengue
virus
den
pdk
passaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000607657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002540168A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/008199 external-priority patent/WO2000057907A2/en
Publication of JP2002540168A publication Critical patent/JP2002540168A/ja
Publication of JP2002540168A5 publication Critical patent/JP2002540168A5/ja
Pending legal-status Critical Current

Links

JP2000607657A 1999-03-26 2000-03-24 多価デングウイルスワクチン Pending JP2002540168A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12631399P 1999-03-26 1999-03-26
US60/126,313 1999-03-26
US18172400P 2000-02-11 2000-02-11
US60/181,724 2000-02-11
PCT/US2000/008199 WO2000057907A2 (en) 1999-03-26 2000-03-24 Multivalent dengue virus vaccine

Publications (2)

Publication Number Publication Date
JP2002540168A JP2002540168A (ja) 2002-11-26
JP2002540168A5 true JP2002540168A5 (enExample) 2007-05-31

Family

ID=26824502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000607657A Pending JP2002540168A (ja) 1999-03-26 2000-03-24 多価デングウイルスワクチン

Country Status (12)

Country Link
US (2) US6638514B1 (enExample)
EP (1) EP1165127B1 (enExample)
JP (1) JP2002540168A (enExample)
KR (1) KR100721745B1 (enExample)
CN (1) CN1191092C (enExample)
AT (1) ATE419006T1 (enExample)
AU (1) AU779280B2 (enExample)
CA (1) CA2368674A1 (enExample)
DE (1) DE60041250D1 (enExample)
ES (1) ES2322327T3 (enExample)
MX (1) MXPA01009683A (enExample)
WO (1) WO2000057907A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60041250D1 (de) * 1999-03-26 2009-02-12 Us Army Multivalenter dengue-virus impfstoff
CA2966716C (en) 2001-05-22 2019-11-26 The Government Of The United States Of America, As Represented By The Cretary, Department Of Health And Human Services Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
CA2611934C (en) * 2005-06-17 2015-11-03 Sanofi Pasteur Dengue serotype 1 attenuated strain
MX2007015872A (es) 2005-06-17 2008-04-21 Sanofi Pasteur Cepa atenuada del serotipo 2 del dengue.
FR2903605A1 (fr) * 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) * 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) * 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
JP2012513591A (ja) * 2008-12-22 2012-06-14 ザ チルドレンズ リサーチ インスティテュート 敗血症の検出のための方法
SG173194A1 (en) 2009-02-17 2011-09-29 Glaxosmithkline Biolog Sa Inactivated dengue virus vaccine with aluminium-free adjuvant
US8968996B2 (en) 2009-06-01 2015-03-03 Takeda Vaccines, Inc. Compositions and methods for rapid immunization against dengue virus
CN102449172A (zh) * 2009-06-01 2012-05-09 伊维拉根公司 施用针对登革病毒的疫苗的组合物和方法
ES2436317T3 (es) * 2010-05-07 2013-12-30 Deutsches Krebsforschungszentrum Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
US9861692B2 (en) 2013-06-21 2018-01-09 Merck Sharp & Dohme Corp. Dengue virus vaccine compositions and methods of use thereof
MX383329B (es) 2014-12-22 2025-03-13 Merck Sharp & Dohme Llc Composiciones de vacuna para el virus del dengue y metodos de uso de las mismas.
EP3316897A4 (en) 2015-07-02 2019-03-13 Primevax Immuno-Oncology, Inc. COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
JP2018535191A (ja) 2015-09-26 2018-11-29 プライムヴァックス イミュノ−オンコロジー，インク． 樹状細胞を産生するための組成物及び方法
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
CN105777877B (zh) * 2016-04-05 2019-03-12 首都医科大学 登革病毒e蛋白阻断肽p4及其应用
CN105801674B (zh) * 2016-04-05 2019-03-12 首都医科大学 登革病毒e蛋白阻断肽p7及其应用
JP2020500847A (ja) 2016-11-16 2020-01-16 プライムヴァックス イミュノ−オンコロジー，インク． 癌の処置のための併用免疫療法
CA3049225A1 (en) 2017-01-04 2018-07-12 PrimeVax Immuno-Oncology, Inc. Compositions and methods for therapy with dengue virus
EP4008343A3 (en) * 2017-03-08 2022-08-24 University of Georgia Research Foundation Inc. Methods and compositions related to increased viral production
MX2019015194A (es) * 2017-06-15 2020-08-03 Primevax Immuno Oncology Inc Composiciones y métodos para terapia de cáncer con virus de dengue y células dendríticas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06181792A (ja) * 1992-06-05 1994-07-05 Nippon Zeon Co Ltd フラビウイルス科に属するウイルスの表面抗原タンパク質を含む非感染性の構造物粒子の製造方法、およびそれに用いる組み換えウイルス
JP3734263B2 (ja) 1993-05-25 2006-01-11 ワイス・ホールディングズ・コーポレイション 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント
WO1996040933A1 (en) * 1995-06-07 1996-12-19 The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Infectious dengue 2 virus pdk-53 as quadravalent vaccine
JP2001525797A (ja) * 1996-10-28 2001-12-11 ザ ユニバーシティ オブ ワシントン ウイルスｒｎａへのミスコーディングリボヌクレオシドアナログの組込みによるウイルス変異の誘導
DE60041250D1 (de) * 1999-03-26 2009-02-12 Us Army Multivalenter dengue-virus impfstoff

Similar Documents

Publication Publication Date Title
JP2002540168A5 (enExample)
AU2012269907B2 (en) Vaccine composition comprising an inactivated chikungunya virus strain
JP2019511533A5 (enExample)
JP2010505801A5 (enExample)
JP5091385B2 (ja) 弱毒生ワクチン
CA2116980A1 (en) Chimeric and/or growth-restricted flaviviruses
EP2345665A3 (en) Flavivirus NS1 subunit vaccine
WO2000057907A3 (en) Multivalent dengue virus vaccine
EP2278012A3 (en) Avirulent, immunogenic flavivirus chimeras
EP3010536A1 (en) Dengue virus vaccine compositions and methods of use thereof
US7790173B2 (en) Pharmaceutical compound capable of induce immune protective response against Dengue virus having the capsid protein of the Dengue virus
Chia et al. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge
CA2341354C (en) Dengue viruses that are replication defective in mosquitos for use as vaccines
ES2637629T3 (es) Inducción de una respuesta inmunitaria frente al virus del dengue usando un enfoque de sensibilización-refuerzo
EP3355916A1 (en) Stable live attenuated recombinant dengue vaccine
Chiba et al. A case of poliomyelitis associated with infection of wild poliovirus in Qinghai Province, China, in October 1999
Simasathein et al. Dengue vaccine
EP4604994A1 (en) Dengue vaccine formulation
Gore Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour
WO2002074963A1 (en) Dengue viruses that are replication defective in mosquitos for use as vaccines
Putnak et al. Inactivated dengue virus vaccine
Rombaut History and future of polivaccination, a personal account
Kelly et al. Recombinant vaccine against dengue virus
BR0010969A (pt) Vacina polivalente antivìrus da dengue
HK1120431A (en) Recombinant flavivirus vaccines